Background: Cachexia affects nearly 50–80% of cancer patients, and most studies have only focused on elderly patients. We investigated preoperative cachexia in gastric cancer (GC) patients by age group and comprehensively analyzed the impact of preoperative cachexia on the prognosis of GC patients in all age groups.
Methods: In total, 575 patients were prospectively analyzed. The effect of preoperative cachexia on overall survival (OS) in all the patients and in patients with different age groups were investigated using log-rank test and Cox proportional hazards regression, respectively.
Results: In total, 35.8% (206 of 575) individuals were diagnosed with cachexia. The median survival of cachexia patients (29.2 months) was shorter than that of non-cachexia patients (35.7 months). Cachexia (HR =1.976, P <0.001), age (HR =1.811, P <0.001), readmission (HR =2.559, P <0.001), tumor size (HR =1.639, P =0.003), TNM stage (stage II: HR =2.215, P =0.017; stage III: HR =5.758, P <0.001), whole stomach cancer (HR =2.639, P <0.001), and combined operation (HR =1.598, P =0.032) were independently associated with worse OS. After grouping by age, cachexia was associated with OS in patients younger than 50 years old (HR =4.947, P =0.029), patients 51–60 years old (HR =2.232, P =0.026), and patients 61–70 years old (HR =1.806, P =0.032), but not in patients older than 71 years (HR =1.411, P =0.119). Further, cachexia only significantly affected the postoperative length of stay (P =0.015) and hospitalization costs (P =0.032) in patients younger than 50 years old.
Conclusions: Preoperative cachexia predicts poor outcome in younger GC patients, and greater attention should be paid to these patients.
Keywords: cachexia, gastric cancer, overall survival, younger patients